ALMKT:EPA
Mauna Kea Technologies SA
€ ०.११
arrow_upward
+१.६७%(+०.००१८) 1D
अक्टोबर २१, १७:२९:४५ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALMKT...
Open
€ ०.११
High
€ ०.११
Low
€ ०.११
Mkt. cap
२.०२ करोड
Avg. vol.
४.४८ लाख
Volume
२.१८ लाख
P/E ratio
०.९३
52-wk high
€ ०.२३
52-wk low
€ ०.०७
EPS
€ ०.१२
Shares outstanding
१९.५३ करोड
No. of employees
५६
Open
€ ०.११
High
€ ०.११
Low
€ ०.११
Mkt. cap
२.०२ करोड
Avg. vol.
४.४८ लाख
Volume
२.१८ लाख
P/E ratio
०.९३
52-wk high
€ ०.२३
52-wk low
€ ०.०७
EPS
€ ०.१२
Shares outstanding
१९.५३ करोड
No. of employees
५६
News stories
From web sources and news partners
www.marketscreener.com
·
१७ घण्टा पहिले
Mauna Kea Technologies reports 24% revenue growth
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA